La Union COVID-19 patient recovers, only 2 remain under treatment | Inquirer News

La Union COVID-19 patient recovers, only 2 remain under treatment

By: - Correspondent / @yzsoteloINQ
/ 10:47 AM May 21, 2020

DAGUPAN CITY –– Another patient infected with the coronavirus disease (COVID-19) from La Union has recovered, bringing to two the number of active cases in that province.

The patient from Sto. Tomas town was discharged from the La Union Medical Center on Wednesday morning, said Pangasinan Governor Francisco Ortega III in a statement.

On the same day, a 3-month-old baby, who caught the virus, was discharged from the Ilocos Training Research and Medical Center.

Article continues after this advertisement

Ortega said it had been eight days since the province recorded new infections. Based on the newly released test results, the province said 15 suspected cases did not contract the disease.

La Union, now under general community quarantine, recorded a total of 21 cases, 15 of whom have been discharged. Four of them, however, have died.

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, COVID-19, La Union, Philippine news updates, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.